Sino Biopharmaceutical: 9-Months Profit Rose on Better Drug Sales

Sino Biopharmaceutical Ltd. (1177.HK) said its net profit for the first three quarters rose 2.5% on year, driven by higher drug sales.

Net profit in the January-to-September period was 2.26 billion yuan (US$321.2 million), compared with CNY2.20 billion over the same period last year, the Chinese drug maker said.

Revenue grew 23% on year to CNY19.32 billion, it said.

For the full year, “the external environment is still full of uncertainties,” the company said, adding it believes its innovative products and cost advantage will allow it to “consolidate market position.”

https://www.marketscreener.com/SINO-BIOPHARMACEUTICAL-LI-6170858/news/Sino-Biopharmaceutical-9-Months-Profit-Rose-on-Better-Drug-Sales-29643586/